Skip to main content
Clinical Trials/NCT04387097
NCT04387097
Completed
Not Applicable

Postoperative Drip-infusion of Remifentanil for Preventing Remifentanil-induced Hyperalgesia- a Retrospective Observative Study

Tri-Service General Hospital1 site in 1 country559 target enrollmentMay 1, 2018
ConditionsHyperalgesia
Interventionsremifentanil

Overview

Phase
Not Applicable
Intervention
remifentanil
Conditions
Hyperalgesia
Sponsor
Tri-Service General Hospital
Enrollment
559
Locations
1
Primary Endpoint
comparison of the numeric rating scale (NRS) between 2 groups
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

The development of remifentanil-induced hyperalgesia (RIH) is an unpleasant experience for surgical patients. An alternative management, gradual withdrawal of remifentanil was effective in prevention of RIH. The investigators designed a simple modality to assess if under withdrawal of remifentanil and further drip-infusion of remifentanil immediately after extubation affected postoperative pain score, the requirement of rescue analgesics, and adverse effects.

Detailed Description

In clinical practice, the gradual withdrawal of remifentanil during surgery is unsatisfied. Thus, the investigators conducted a simple modality in a single center retrospective cohort study to assess how under baseline gradual withdrawal of remifentanil and further drip infusion of remifentanil immediately after extubation affected postoperative pain score and use of analgesics.

Registry
clinicaltrials.gov
Start Date
May 1, 2018
End Date
July 22, 2019
Last Updated
5 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Yi-hsuan Huang

Principal Investigator

Tri-Service General Hospital

Eligibility Criteria

Inclusion Criteria

  • American Society of Anesthesiologists (ASA) score of I-III patients receiving total intravenous anesthesia

Exclusion Criteria

  • The use of inhalation agents or propofol combined with inhalation anesthesia
  • Pregnancy
  • Previous substance abuse
  • Known allergies to opioids, propofol or any drugs used in the study
  • History of neuropsychiatric disorder
  • Age \< 20 years or \> 80 years

Arms & Interventions

gradual withdrawal following by drip-infusion of remifentanil

In the end of the surgery, gradual withdrawal of remifentanil was prescribed until the endotracheal tube was extubated. Following by drip-infusion of remifentanil for 30 minutes was administered immediately after tracheal extubation.

Intervention: remifentanil

Outcomes

Primary Outcomes

comparison of the numeric rating scale (NRS) between 2 groups

Time Frame: one hour

NRS scores is labeled from zero to ten, with zero being an example of someone with no pain and ten being the worst pain possible.

requirement for rescue analgesics

Time Frame: one hour

postoperative requirement for rescue analgesics

Secondary Outcomes

  • type of surgery(three hours)
  • surgical site(three hours)

Study Sites (1)

Loading locations...

Similar Trials